Using a mathematical model, researchers found that good hygiene can reduce the harmful effects of antibiotic use.
Academic rigor, journalistic flair
Articles on Antibiotic resistance
Displaying 1 - 20 of 177 articles
Antibiotics are a cornerstone of modern medicine, but resistance is a big challenge – and it’s possibly being exacerbated by the COVID pandemic.
Bacterial infections are a growing global challenge. This is due to antibiotic-resistant bacteria, and researchers are turning to AI to develop new drugs.
These shortages are a result of rising demand and supply chain bottlenecks. But there are things that can be done to reduce harms to public health.
It is illegal to share prescription drugs with friends and family.
The US currently has only one antibiotic available to treat gonorrhea – and it’s becoming less effective.
Most antibiotics work by killing bacteria. But this also helps them to become resistant. If we render bacteria harmless to us, rather than kill them, it’s a win-win.
With the dual threats of antibiotic resistance and emerging pandemics, finding new drugs becomes even more urgent. A trove of medicines may be lying under our nose.
When humans eat fish, mussels and other foods containing antibiotics, the residual antibiotics may cause bacterial pathogens to become resistant.
Scientists discover why antibiotics make life-threatening fungal infections such as invasive candidiasis more probable.
Antimicrobial resistance disproportionately affects the world’s poorest and most vulnerable populations in low- and middle-income countries.
Canada lags behind other developed countries in access to newer antimicrobials. Here’s why that matters, and what can be done about it.
Latest numbers show antimicrobial resistant infections contributed to 4.95 millions deaths globally in 2019.
The probiotic decreases the presence of pathogens in the animal’s gut and can be used safely on a daily basis.
After a nose swab tests positive for a virus or bacteria, scientists can use the sample’s genetic sequence to figure out where and when the pathogen emerged and how fast it’s changing.
The quest to find treatment for COVID-19, and the uncertainty surrounding the clinical outcome, necessitates the use of antibiotics in the treatment package.
Antimicrobial resistance kills around 700,000 people worldwide annually. It is a top-ten global health threat.
If no action is taken to address antibiotic resistance, infections from multidrug-resistant bacteria could cause 10 million deaths each year by 2050.
Viruses have gotten a bad rap for the many illnesses and pandemics they’ve caused. But viruses are also genetic innovators – and possibly the pioneers of using DNA as the genetic blueprint of life.
Penicillin originally came from a fungus, and with thousands of fungi to explore, Aotearoa New Zealand has a potential treasure trove of bacteria-killing compounds.
Top contributors
-
Professor of Public Health, Bond University
-
Professor, The University of Queensland
-
Research Fellow in Microbiology, University of Glasgow
-
Director Of Medicine, The Maitland and Kurri Kurri Hospital, University of Newcastle
-
Senior Lecturer in Microbiology, Aston University
-
Visiting Research Fellow, History of Biomedical Sciences, University of Cambridge
-
Infectious Diseases Physician, Senior Lecturer, James Cook University and, The University of Queensland
-
Professor at ANU Medical School; Senior Staff Specialist Infectious Diseases; General Physician, Australian National University
-
Professor in Infectious Diseases Epidemiology, Monash University
-
Senior Research Fellow, School of Biomedical Sciences, The University of Western Australia
-
Assistant Professor, Johns Hopkins University
-
South African Research Chair in Antibiotic Resistance and Professor in Pharmaceutical Sciences, University of KwaZulu-Natal
-
Professor of Infectious Diseases, University of Cape Town
-
Clinical Lecturer and GP, University of Oxford
-
Professor of Biochemistry and Biomedical Sciences, McMaster University
